First, they slow gastric emptying, keeping food in your stomach longer and creating prolonged fullness after meals
If metabolic optimization and mitochondrial support are priorities, tirzepatide niacinamide or NAD+ precursor formulations are logical choices
Why affordability matters: GLP-1 therapy requires sustained use to maintain metabolic benefit, and cost-related discontinuation remains a significant challenge in obesity and diabetes management
Pharmaceutical-grade tirzepatide is covered by many insurance plans for approved indications
Counsel patients regarding the potential risk for MTC with the use of OZEMPIC and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness)
When used alongside GLP-1 receptor agonists, this could theoretically provide additive glucose-lowering effects without increasing hypoglycaemia risk for most patients, as both agents work through glucose-dependent mechanisms